Cargando…
Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS)
Bladder cancer is known as the world’s ninth most prevalent cancer in 2012. New cytotoxic drugs have created considerable progress in the treatment. Gallic acid (GA) has been shown to inhibit carcinogenesis in animal models and various cancer cell lines. The aim of the present study was to evaluate...
Autores principales: | Liao, Chung-Chia, Chen, Shu-Chun, Huang, Hui-Pei, Wang, Chau-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322229/ https://www.ncbi.nlm.nih.gov/pubmed/29567231 http://dx.doi.org/10.1016/j.jfda.2017.06.006 |
Ejemplares similares
-
Strategies in megasynthase engineering – fatty acid synthases (FAS) as model proteins
por: Fischer, Manuel, et al.
Publicado: (2017) -
Analysis of the co-translational assembly of the fungal fatty acid synthase (FAS)
por: Fischer, Manuel, et al.
Publicado: (2020) -
Inhibition of Candida parapsilosis Fatty Acid Synthase (Fas2) Induces Mitochondrial Cell Death in Serum
por: Nguyen, Long Nam, et al.
Publicado: (2012) -
Gallic acid
por: Zhao, Jianping, et al.
Publicado: (2011) -
Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer
por: Xiong, Qiao, et al.
Publicado: (2022)